Filing Flows › Collegium Pharmaceutical (COLL) › Q1 2025
Collegium Pharmaceutical (COLL) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
Collegium Pharmaceutical (COLL) reported revenue of $178M for the first quarter 2025 (Q1 2025), +23% from a year earlier and -2% from the quarter before. Operating margin was 12.2%, net earnings $2.4M (1.4% of revenue).
Collegium Pharmaceutical, Q1 2025: revenue $178M (+23% year over year), operating margin 12.2%, net earnings $2.4M, operating cash flow $55.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $178M | -2% | +23% |
| Gross profit | $97.3M | -1% | +6% |
| Operating profit | $21.7M | -43% | -56% |
| Net earnings | $2.4M | -81% | -91% |
| Operating cash flow | $55.4M | -35% | -11% |
| Free cash flow | $54.6M | -35% | -11% |
What changed
Revenue was $177.8M in Q1 2025, up 23% year over year and down 2% from the previous quarter. Belbuca was the largest line at 29% of revenue. Xtampza ER added $1.8M year over year (up 4%), 6% of the total change. Symproic declined 15%.
Gross margin was 54.8%, down 8.4 points from a year earlier. Operating profit was $21.7M, a 12.2% margin (down 21.9 points year over year). Operating profit fell $27.8M even though revenue rose $32.8M versus a year earlier, so costs grew faster than sales. Operating expenses grew 80% against revenue growth of 23%. Net earnings were $2.4M, down 91% year over year. The effective tax rate was 22.6%.
Operating cash flow was $55.4M (down 11% year over year), 2292% of net earnings. Non-cash charges added back $56.6M of depreciation and amortization and $11.5M of share-based compensation. Working capital and other items used $15.1M. Capital expenditures of $798K left free cash flow of $54.6M.
Questions
What was Collegium Pharmaceutical's revenue in the first quarter 2025?
Collegium Pharmaceutical (COLL) reported revenue of $178M for the first quarter 2025 (Q1 2025), +23% from a year earlier and -2% from the quarter before.
Was Collegium Pharmaceutical profitable in the first quarter 2025?
Operating profit was $21.7M (12.2% of revenue) and net earnings $2.4M.